An observation on erythrocyte and reticulocyte in pregnant women with β-thalassemia
Yanling Ding
Abstract
Yanling Ding
Abstract
Objective To explore the change in erythrocyte parameters (MCV, MCH, MCHC, and RDW) and reticulocyte parameters (RET%, RET#, IRF, LFR, MFR, and HFR) in pregnant women with β-thalassemia. Methods Erythrocyte and reticulocyte parameters were measured in pregnant women with β-thalassemia by a Sysmex XE-2100 automated hematology analyzer and the outcomes were compared with those from healthy pregnant women and from non-pregnant women with β-thalassemia. Results The levels of MCV, MCH, and LFR were lower but the levels of RDW, RET%, RET# , IRF, MFR, and HFR were higher in pregnant women with β-thalassemia than in healthy pregnant women. The levels of MCV, MCH, IRF, MFR and HFR were higher whereas LFR level was lower in pregnant women with β-thalassemia than in non-pregnant women with β-thalassemia. Conclusions The hematopoietic function becomes more active and the changes in erythrocyte and reticulocyte parameters are more obvious in pregnant women with β-thalassemia. MCV, MCH, RDW, RET%, RET#, IRF, LFR, MFR, and HFR can be used as reference markers for screening thalassemia in pregnant women.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the change in erythrocyte parameters (MCV, MCH, MCHC, and RDW) and reticulocyte parameters (RET%, RET#, IRF, LFR, MFR, and HFR) in pregnant women with β-thalassemia. Methods Erythrocyte and reticulocyte parameters were measured in pregnant women with β-thalassemia by a Sysmex XE-2100 automated hematology analyzer and the outcomes were compared with those from healthy pregnant women and from non-pregnant women with β-thalassemia. Results The levels of MCV, MCH, and LFR were lower but the levels of RDW, RET%, RET# , IRF, MFR, and HFR were higher in pregnant women with β-thalassemia than in healthy pregnant women. The levels of MCV, MCH, IRF, MFR and HFR were higher whereas LFR level was lower in pregnant women with β-thalassemia than in non-pregnant women with β-thalassemia. Conclusions The hematopoietic function becomes more active and the changes in erythrocyte and reticulocyte parameters are more obvious in pregnant women with β-thalassemia. MCV, MCH, RDW, RET%, RET#, IRF, LFR, MFR, and HFR can be used as reference markers for screening thalassemia in pregnant women.
Key concepts: Thalassemia, Reticulocyte, Medicine, Hematology, Hematology analyzer, Obstetrics, Internal medicine, Biology